Search results
Vertex (VRTX) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 24 hours agoVertex Pharmaceuticals Incorporated VRTX is scheduled to release first-quarter 2024 results on May...
Vertex Pharmaceuticals (VRTX) to Release Earnings on Monday
ETF DAILY NEWS· 2 days agoVertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) will be announcing its earnings results after the market closes on Monday, May 6th. Analysts expect ...
Sigma Planning Corp Sells 1,061 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
ETF DAILY NEWS· 6 days agoSigma Planning Corp cut its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 37.3% during the 4th quarter, according to its ...
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?
Zacks via Yahoo Finance· 2 days agoVertex (VRTX) doesn't possess the right combination of the two key ingredients for a likely earnings...
Vertex Pharmaceuticals (VRTX) Falls More Steeply Than Broader Market: What Investors Need to Know
Zacks via Yahoo Finance· 5 days agoVertex Pharmaceuticals (VRTX) closed the most recent trading day at $397.70, moving -0.76% from the...
(VRTX) - Analyzing Vertex Pharmaceuticals's Short Interest By Benzinga
Investing.com· 6 days agoVertex Pharmaceuticals's (NYSE:VRTX) short percent of float has fallen 3.75% since its last report....
EU expands cystic fibrosis treatment for infants with KALYDECO By Investing.com
Investing.com· 5 days agoVertex Pharmaceuticals (NASDAQ:VRTX) has announced the European Commission's approval to expand the...
...Recreate $10B Cystic Fibrosis Success - This Time Focused On Pain Management Drugs - Vertex ...
Benzinga· 5 days agoVertex Pharmaceuticals Inc‘s VRTX blockbuster drug Trikafta for cystic fibrosis (CF) has shown remarkable efficacy, potentially extending the lives of some ...
The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals
Zacks via Yahoo Finance· 5 days agoStocks recently featured in the blog include: Biogen BIIB, Bristol Myers Squibb BMY, Incyte INCY and...
Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth
Reuters via Yahoo News· 6 days agoMammoth's CRISPR-based gene editing platform and Regeneron's delivery technologies will be used to...